A comprehensive insight into the correlation between ncRNAs and the Wnt/beta-catenin signalling pathway in gastric cancer pathogenesis

During the past decades, gastric cancer (GC) has emerged as one of the most frequent malignancies with a growing rate of prevalence around the world. Despite considerable advances in therapeutic methods, the prognosis and management of patients with gastric cancer (GC) continue to be poor. As one of the candidate molecular targets in the treatment of many types of cancer, the Wnt/beta-catenin pathway includes a family of proteins that have important functions in adult tissue homeostasis and embryonic development. The aberrant regulation of Wnt/beta-catenin signaling is strongly correlated with the initiation and development of numerous cancers, including GC. Therefore, Wnt/beta-catenin signaling has been identified as one of the main targets for extending therapeutic approaches for GC patients. Non-coding RNAs (ncRNAs), including microRNAs and long ncRNAs, are important components of epigenetic mechanisms in gene regulation. They play vital roles in various molecular and cellular processes and regulate many signaling pathways, such as Wnt/beta-catenin pathways. Insights into these regulatory molecules involved in GC development may lead to the identification of potential targets for overcoming the limitations of current therapeutic approaches. Consequently, this review aimed to provide a comprehensive overview of ncRNAs interactions involved in Wnt/beta-catenin pathway function in GC with diagnostic and therapeutic perspectives.

Automated summary

Gastric cancer is a prevalent malignancy worldwide, with poor prognosis and management despite therapeutic advances. The Wnt/beta-catenin pathway is an important target for gastric cancer treatment. Non-coding RNAs play crucial roles in gene regulation and are involved in signaling pathways such as Wnt/beta-catenin. Understanding the role of these regulatory molecules in gastric cancer development may lead to the identification of potential therapeutic targets.